Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.SummaryDifference0.9%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check55 days agoChange DetectedThe page now lists 57 locations for the study, an increase from 56, and includes a new location in Bruxelles, Belgium. Additionally, several dates have been updated, including the addition of April 2025 dates.SummaryDifference1.0%
Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.